Your browser doesn't support javascript.
loading
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models.
Cho, Shih-Feng; Lin, Liang; Xing, Lijie; Li, Yuyin; Wen, Kenneth; Yu, Tengteng; Hsieh, Phillip A; Munshi, Nikhil; Wahl, Joachim; Matthes, Katja; Friedrich, Matthias; Arvedson, Tara; Anderson, Kenneth C; Tai, Yu-Tzu.
Afiliación
  • Cho SF; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Lin L; Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, and.
  • Xing L; Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Li Y; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Wen K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Yu T; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Hsieh PA; School of Biotechnology, Tianjin University of Science and Technology, Tianjin, People's Republic of China.
  • Munshi N; Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, People's Republic of China.
  • Wahl J; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Matthes K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Friedrich M; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Arvedson T; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Anderson KC; Amgen Research GmbH, Munich, Germany; and.
  • Tai YT; Amgen Research GmbH, Munich, Germany; and.
Blood Adv ; 4(17): 4195-4207, 2020 09 08.
Article en En | MEDLINE | ID: mdl-32898244
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article País de afiliación: Marruecos